4884 — Kringle Pharma Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareHighly SpeculativeMicro CapSucker Stock

Annual balance sheet for Kringle Pharma, fiscal year end - September 30th, JPY millions except per share, conversion factor applied.

	2021 September 30th	2022 September 30th	2023 September 30th	2024 September 30th	2025 September 30th
Period Length:	—	—	—	—	—
Source:	Yuho	Yuho	Yuho	Yuho	Yuho
Standards:	JAS	JAS	JAS	JAS	JAS
Status:	Final	Final	Final	Final	Final
Cash and Equivalents
Cash and Short Term Investments	2,138	2,756	2,136	2,313	1,619
Net Total Accounts Receivable
Net Total Receivables	83.4	67.9	81.8	57.2	60.7
Total Inventory
Prepaid Expenses
Total Other Current Assets
Total Current Assets	2,635	3,208	2,618	2,756	2,055
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	0	0	0	0	—
Other Long Term Assets
Total Assets	2,636	3,209	2,619	2,757	2,079
Accrued Expenses
Notes Payable / Short Term Debt
Total Other Current Liabilities
Total Current Liabilities	127	163	209	128	109
Total Long Term Debt
Total Debt
Total Other Liabilities
Total Liabilities	129	420	597	649	770
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Treasury Stock
Other Equity
Total Equity	2,506	2,789	2,022	2,108	1,309
Total Liabilities & Shareholders' Equity	2,636	3,209	2,619	2,757	2,079
Total Common Shares Outstanding